CYTOF

distress 6/10 · elevated risk

$0.060%today-59% from 52w high

altamiratherapeutics.com11 employeesFounded 2003Hamilton, BermudaBiotechnology

Revenue

pre-revenue

Liquidity

$2M

Runway

0.3 yrs

Shares 1y

-90%

Price & events

-45.5% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.0%

-45.5%

-40.0%

-94.5%

-100.0%

All

Overview

Market Cap: $279.73K
Volume: 0
52 Week Range: $0.05 – $0.15
Total Shares: 4.66M
Float Shares: 4.12M
Short %: 1.35%
% Held by Insiders: 18.80%
% Held by Institutions: 4.00%
Beta: 2.74

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 4,662,080 · 0 offerings/1y · 0 PIPEs

2024-11-14SC 13Gstrategic_stake
2024-09-18424B4offering
2024-09-17EFFECTshelf_effective
2024-09-16F-1/Ashelf_registration
2024-09-16F-1/Ashelf_registration
2024-08-22F-1shelf_registration
2024-07-12EFFECTshelf_effective

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified